Create a free research account to view current pricing and place an order.
How does DSIP work in research models?
DSIP is a sleep-associated neuropeptide researched for sleep architecture, stress-response modulation, and neuroendocrine rhythm effects. Human response appears highly individualized.
What is the half-life of DSIP?
Half-life: Short acting.
Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.
Research dosing reference
100-500 mcg at bedtime or sleep-protocol timing.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 100 mcg | 4 units |
| 250 mcg | 10 units |
| 500 mcg | 20 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
How is DSIP reconstituted?
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 5 mg | 2 mL BAC Water | 0.025 mg/unit |
Injection timing
Evening or bedtime research timing is typical; avoid first exposure before an important sleep/work cycle.
Beginner escalation
Start low because sedation, stimulation, or lack of response can be individualized.
Side-effect mitigation
Monitor vivid dreams, morning grogginess, paradoxical stimulation, headache, or sleep disruption.
Stack compatibility
Pairs cautiously with sleep protocols; avoid combining with multiple sedating or neuroactive agents initially.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Sleep-focused protocols should be reassessed after 1-3 weeks. Continue only if sleep quality improves without next-day impairment or paradoxical stimulation.
Frequently asked questions
What is DSIP and how is it studied?
DSIP is a sleep-associated neuropeptide researched for sleep architecture, stress-response modulation, and neuroendocrine rhythm effects. Human response appears highly individualized. DSIP is catalogued in the Cognitive / Neuro group of this reference and is studied in laboratory and in-vitro models only.
What is known about the half-life of DSIP?
Reference half-life for DSIP: short acting. Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal.
How is DSIP stored?
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.
How is DSIP reconstituted for laboratory work?
The reference reconstitution for the 5 mg vial is 2 mL BAC Water, which gives a concentration of about 2.5 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.
Is DSIP FDA approved?
No. The research-grade DSIP described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.
DSIP product overview · DSIP cost · All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration